Ana Hidalgo‐Simon
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions 4
-
- Pharmaceutical studies and practices 3
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life 4
- Statistics and Probability top 10%
-
- Biomedical Ethics and Regulation 3
-
- CAR-T cell therapy research 3
- Polyomavirus and related diseases 3
-
- Plant Virus Research Studies 2
-
- Biosimilars and Bioanalytical Methods 2
- Co-authors
- Peter ArlettXavier KurzGuido RasiNikolai C. BrunFrancesco PignattiIrmgard EichlerHans‐Georg EichlerA. J. B. Humphreys
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)British Journal of Clinical Pharmacology (3 papers)Vaccine (2 papers)
- Partner nations
- NetherlandsGermanyAustria
In The Last Decade
Ana Hidalgo‐Simon
14 papers receiving 337 citations
Peers
Comparison fields: 5 of 89
- Toxicology 69
- Pediatrics, Perinatology and Child Health 74
- Economics and Econometrics 99
- Statistics and Probability 27
- Geriatrics and Gerontology 12
Countries citing papers authored by Ana Hidalgo‐Simon
This map shows the geographic impact of Ana Hidalgo‐Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Hidalgo‐Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Hidalgo‐Simon more than expected).
Fields of papers citing papers by Ana Hidalgo‐Simon
This network shows the impact of papers produced by Ana Hidalgo‐Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Hidalgo‐Simon. The network helps show where Ana Hidalgo‐Simon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Hidalgo‐Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 2 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 114 | |
| 8 | 2018 | 25 | |
| 9 | 2015 | 2 | |
| 10 | 2015 | 17 | |
| 11 | 2014 | 48 | |
| 12 | 2012 | 14 | |
| 13 | 2012 | 40 | |
| 14 | 2012 | 47 | |
| 15 | 2011 | 22 |
About Ana Hidalgo‐Simon
Ana Hidalgo‐Simon is a scholar working on Toxicology, Statistics and Probability, Oncology, Economics and Econometrics and Pediatrics, Perinatology and Child Health, having authored 15 papers that have together received 355 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Biomedical Ethics and Regulation (3 papers), CAR-T cell therapy research (3 papers), Pharmaceutical studies and practices (3 papers), Polyomavirus and related diseases (3 papers), Plant Virus Research Studies (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Toxicology (69 citations), Pediatrics, Perinatology and Child Health (74 citations), Economics and Econometrics (99 citations), Statistics and Probability (27 citations) and Geriatrics and Gerontology (12 citations). Ana Hidalgo‐Simon has collaborated with scholars based in Netherlands, Germany and Austria. Frequent co-authors include Peter Arlett, Xavier Kurz, Guido Rasi, Nikolai C. Brun, Francesco Pignatti, Irmgard Eichler, Hans‐Georg Eichler, A. J. B. Humphreys, Spiros Vamvakas and Kevin Blake. Their work appears in journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Vaccine, Nature Reviews Nephrology and Pediatric Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.